PI3K/AKT inhibitors have been demonstrated to suppress tumor cell proliferation in vitro and drive tumor cells to join the apoptotic program (Gadgeel and Wozniak, 2013; Sun et al., 2015; Chen et al., 2020). Here, PIK3CA is linked to neoplasm.